找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cell Culture Engineering; Wei-Shou Hu Book 2006 Springer-Verlag Berlin Heidelberg 2006 Biotechnology.Cell Culture.Escherichia coli.biochem

[復制鏈接]
查看: 54251|回復: 35
樓主
發(fā)表于 2025-3-21 18:03:56 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Cell Culture Engineering
編輯Wei-Shou Hu
視頻videohttp://file.papertrans.cn/223/222768/222768.mp4
概述Covers trends in modern biotechnology.All aspects of this interdisciplinary technology, where knowledge, methods and expertise are required from chemistry, biochemistry, microbiology, genetics, chemic
叢書名稱Advances in Biochemical Engineering/Biotechnology
圖書封面Titlebook: Cell Culture Engineering;  Wei-Shou Hu Book 2006 Springer-Verlag Berlin Heidelberg 2006 Biotechnology.Cell Culture.Escherichia coli.biochem
描述Since the introduction of recombinant human growth hormone and insulin a quarter century ago, protein therapeutics has greatly broadened the ho- zon of health care. Many patients suffering with life-threatening diseases or chronic dysfunctions, which were medically untreatable not long ago, can attest to the wonder these drugs have achieved. Although the ?rst generation of p- tein therapeutics was produced in recombinant Escherichia coli, most recent products use mammalian cells as production hosts. Not long after the ?rst p- duction of recombinant proteins in E. coli, it was realized that the complex tasks of most post-translational modi?cations on proteins could only be ef?ciently carried out in mammalian cells. In the 1990s, we witnessed a rapid expansion of mammalian-cell-derived protein therapeutics, chie?y antibodies. In fact, it has been nearly a decade since the market value of mammalian-cell-derived protein therapeutics surpassed that of those produced from E. coli. A common characteristic of recent antibody products is the relatively large dose required for effective therapy, demanding larger quantities for the treatment of a given disease. This, coupled with the broadeni
出版日期Book 2006
關鍵詞Biotechnology; Cell Culture; Escherichia coli; biochemical engineering; cell biology; post-translational
版次1
doihttps://doi.org/10.1007/11751571
isbn_softcover978-3-642-07051-8
isbn_ebook978-3-540-34007-2Series ISSN 0724-6145 Series E-ISSN 1616-8542
issn_series 0724-6145
copyrightSpringer-Verlag Berlin Heidelberg 2006
The information of publication is updating

書目名稱Cell Culture Engineering影響因子(影響力)




書目名稱Cell Culture Engineering影響因子(影響力)學科排名




書目名稱Cell Culture Engineering網絡公開度




書目名稱Cell Culture Engineering網絡公開度學科排名




書目名稱Cell Culture Engineering被引頻次




書目名稱Cell Culture Engineering被引頻次學科排名




書目名稱Cell Culture Engineering年度引用




書目名稱Cell Culture Engineering年度引用學科排名




書目名稱Cell Culture Engineering讀者反饋




書目名稱Cell Culture Engineering讀者反饋學科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 22:27:45 | 只看該作者
板凳
發(fā)表于 2025-3-22 00:46:00 | 只看該作者
地板
發(fā)表于 2025-3-22 06:27:07 | 只看該作者
Towards Industrial Application of Quasi Real-Time Metabolic Flux Analysis for Mammalian Cell Culturstablished bioreaction network. The utility of thisapproach towards optimizing bioreactor operation was demonstrated for CHO cells cultivated in 15?Lperfusion reactors at 20?×?10.?cells/mL. Medium compositionand dilution rates were changed to obtain several steady states with varying glucose and glu
5#
發(fā)表于 2025-3-22 09:53:36 | 只看該作者
6#
發(fā)表于 2025-3-22 14:37:29 | 只看該作者
Book 2006f health care. Many patients suffering with life-threatening diseases or chronic dysfunctions, which were medically untreatable not long ago, can attest to the wonder these drugs have achieved. Although the ?rst generation of p- tein therapeutics was produced in recombinant Escherichia coli, most re
7#
發(fā)表于 2025-3-22 19:18:20 | 只看該作者
8#
發(fā)表于 2025-3-22 23:10:51 | 只看該作者
,Established Bioprocesses for Producing Antibodies as a?Basis for Future Planning,res processes for theproduction of antibodies for diagnosis and for antibody fragments..The analysis defines the likely routes of future production in a?sector where demanding regulationsconstrain new technology. It also indicates what levels of performance new approaches will need to meetto be competitive.
9#
發(fā)表于 2025-3-23 04:01:42 | 只看該作者
0724-6145 from chemistry, biochemistry, microbiology, genetics, chemicSince the introduction of recombinant human growth hormone and insulin a quarter century ago, protein therapeutics has greatly broadened the ho- zon of health care. Many patients suffering with life-threatening diseases or chronic dysfuncti
10#
發(fā)表于 2025-3-23 06:26:27 | 只看該作者
0724-6145 A common characteristic of recent antibody products is the relatively large dose required for effective therapy, demanding larger quantities for the treatment of a given disease. This, coupled with the broadeni978-3-642-07051-8978-3-540-34007-2Series ISSN 0724-6145 Series E-ISSN 1616-8542
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-9 13:39
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
双柏县| 灌云县| 清苑县| 安国市| 英山县| 和平区| 邹城市| 朝阳市| 富阳市| 伊通| 西乌珠穆沁旗| 昌图县| 秦安县| 大埔县| 关岭| 石阡县| 西盟| 利辛县| 石阡县| 辽阳市| 甘孜| 安岳县| 永春县| 策勒县| 加查县| 诸城市| 富宁县| 神农架林区| 锦屏县| 杨浦区| 海丰县| 洛隆县| 吉林省| 南昌县| 湘阴县| 荔波县| 延边| 琼海市| 清远市| 万载县| 延寿县|